News and Announcements
YPB strengthens position in Government document security
- Published July 31, 2015 4:32PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
31st July 2015, ASX Announcement
Specialist security consulting business Intellectual Property Protection Co Ltd (IPP), a wholly owned subsidiary of anti-counterfeiting technology company YPB Group Limited (ASX:YPB) (“YPB, the Company”) , has signed a Memorandum of Cooperation (MOC) with Foilmakers Australia Pty Ltd (FMA) for the production, marketing and sales of three IPP products.
Under the new deal two of the three products, VariSec Foil and Mul-T-Gram (MTG), will be manufactured FMA with IPP responsible for the marketing and sales of the products. The third product, Bi-Component Security Thread, will also be marketed by IPP with manufacturing to be completed by fiber technologies.
This IPP technology has been adapted into more than 100 million e-Passports worldwide to date, generating approximately $2.5 million in revenue to date.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
